private sector JOINs FORCES WITH the one by one campaign  to raise $4 million in support of the africa cdc’s pact initiative

Addis Ababa, Ethiopia, New York, USA, 20th October, 2020: The One by One: Target COVID-19 Campaign has been able to raise a total of $4 million to support Africa CDC’s Partnership to Accelerate COVID-19 Testing (PACT) initiative, which aims to strengthen testing and PPE capacity for COVID-19 across Africa. Smile 4 Humanity has made a 3:1 match by committing US$ 3 million to a $1 million donation, which was raised through the Michael & Susan Dell Foundation and other private sector partners towards the purchase of COVID-19 rapid antibody test kits and medical-grade masks for healthcare professionals. 


“This donation from Smile 4 Humanity Foundation Germany, Michael & Susan Dell Foundation,  and BYKA Sustainability Group, Canada along with Angelworld Biotech, UAE through the One by One: Target COVID-19 campaign is an incredible investment in the strong testing response we need across African nations.  This investment will help the Africa CDC scale up COVID surveillance. Multi-sectoral partnerships like this one are the only way we can adequately respond to this pandemic.”

- Dr. John Nkengasong, Director of the Africa Centers for Disease Control and Prevention


All FDA-approved material purchases are being made through accredited distributors.  The campaign will oversee the procurement cycle for a total of 350,000 Angelworld Biotech Anti-SARS-CoV2 Rapid Test Kits which will be sent to the Africa CDC this week. 


“We would like to thank the One By One Campaign and the Africa CDC team for their incredible cooperation.   We also thank our partner BYKA Sustainability Group along with Angelworld Biotech, UAE for their support. We are excited by private sector joining our donation program” said Rajendra Chaudhari, Vice President of the Smile4Humanity Foundation


“We are honored to support Africa CDC’s COVID-19 Continental Response strategy through our PPE subsidization program ensuring that vulnerable countries receive the critical PPE and testing they need. Shortage of critical medical supplies & resources are the biggest challenges in Africa’s COVID-19 response.  We aim to continue supporting the Africa CDC’s COVID-19 response following this first round of donations.”

 - Cosmin Scortea , Chairman of the Smile 4 Humanity Foundation. 


To date, the Africa CDC has distributed over 3 million tests and deployed over 200 health workers across AU member states to combat the COVID virus. With a population of over 1 billion people, testing is still in short supply. Widespread testing is essential in order to properly test, trace, and isolate cases and treat those infected to reduce cases across the continent and allow states to reopen their economies safely.


The One by One: Target COVID-19 campaign aims to use this first round of investment to catalyze further action from the private sector in order to meet Africa CDC’s testing goal of 8000 tests per million population. 


The One by One: Target COVID-19 campaign was launched as a sub-campaign of the One by One: Target 2030 Campaign by the Africa CDC, the African Union, the Jakaya Mrisho Kikwete Foundation and The Access Challenge to mobilize resources for Africa CDC’s PACT initiative and to promote universal access of COVID-19 testing and PPE across the continent. The campaign pairs this resource mobilization with strategic communications and a mass media campaign to disseminate accurate public health information through prominent media houses, celebrities, and influencers to galvanize individual action against COVID-19. 


The campaign invites global donors and partners to join the One by One: Target COVID-19 campaign in support of Africa CDC’s COVID-19 Response across the continent. 


For media enquiries

Asad Lilani,, Director of Political Strategy, The Access Challenge

Rajendra Chaudhari,, Smile4Humanity Foundation


Additional Information

The Africa CDC

Africa CDC is a specialized technical institution of the African Union that strengthens the capacity and capability of Africa’s public health institutions as well as partnerships to detect and respond quickly and effectively to disease threats and outbreaks, based on data-driven interventions and programmes. Learn more at:


Smile 4 Humanity Foundation

Smile 4 Humanity Foundation helps communities &countries to procure PPE’s and medicines through a subsidized program, help communities by providing medical diagnostics services using Mini Labs, , provide new technologies to improve living conditions, and preserve life by procuring PPE products for low-income countries. Learn more at :


Michael & Susan Dell Foundation 

The Michael & Susan Dell Foundation is dedicated to improving the lives of children living in urban poverty across the world. Headquartered in Austin, TX with additional offices in New Delhi, India, and Cape Town, South Africa, the Dell Foundation funds programs that foster high-quality public education and childhood wellness and improve the economic stability of families living in poverty. The foundation has committed more than $1.7 billion to global children's issues and community initiatives to date.Learn more at:


One by One: Target 2030

One by One: Target 2030 is a multi-level advocacy campaign led by The Access Challenge, the African Union, and the Jakaya Mrisho Kikwete Foundation in support of WHO's UHC agenda. The Campaign is designed to help drive the collaborative commitment of all African governments to meaningful progress on Universal Access to Health. The One by One coalition launched One by One: Target COVID-19 in April 2020 in response to the COVID-19 pandemic, and see this as an opportunity to build back stronger by developing systems today that can ensure UHC for tomorrow. 

For more information and to sign up for the campaign newsletter, please visit Follow the Campaign and the Access Challenge on twitter: @OnebyOne2030 @TheAChallenge


BYKA Sustainability Group

BYKA Group provides a unique collaborative approach to developing sustainable businesses in order to maximize benefit to communities. Our finance, technology, mentoring, knowledge transfer capability helps our partners realize their vision while respecting the community and environment in which we operate. Learn more at


Angelworld Biotech

Angelworld Biotech is a high growth biotech company focused on developing rapid diagnostic IVD test kits for major diseases including COVID 19, Influenza A/B, Dengue Fever, Malaria, Hepatitis, Cancer etc. Its goal is to deliver the Dr’s Clinic in your pocket from testing, diagnosis to treatment through digitizing the patient journey and making primary healthcare more accessible, affordable, and available to everyone. Learn more at

  • Facebook
  • Twitter
  • Instagram
  • YouTube
Powered by The Access Challenge, secretariat of the One by One: Target 2030 Campaign
Get involved: Careers

©️ 2020 All rights reserved.